IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i2p886-d724240.html
   My bibliography  Save this article

Symptomatic SARS-CoV-2 Infection with Ageusia after Two mRNA Vaccine Doses

Author

Listed:
  • Vito Carlo Alberto Caponio

    (Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy)

  • Maria Rosaria Lipsi

    (Microbiology and Virology Unit, Policlinico Riuniti Foggia Hospital, 71122 Foggia, Italy)

  • Francesca Fortunato

    (Hygiene Unit, Policlinico Riuniti Foggia Hospital, 71122 Foggia, Italy
    Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy)

  • Fabio Arena

    (Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy)

  • Lorenzo Lo Muzio

    (Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy
    Consorzio Interuniversitario Nazionale per la Bio-Oncologia, 66100 Chieti, Italy)

Abstract

To raise awareness about preventive measures in COVID-19 pandemic, even though fully vaccinated. Although recent trials showed high efficacy of vaccines in preventing symptomatic infections, there are some individuals experiencing symptomatic SARS-CoV-2 infection. In this case report, a fully vaccinated young dental practitioner experienced symptomatic SARS-CoV-2 infection 55 days postvaccination with BNT162b2 Pfizer vaccine with evident ageusia. Diagnostic swabs were performed and used for viral genome sequencing. The patient fully recovered 15 days after diagnosis. Loss of smell and taste, together with nasal congestion were the main reported symptoms. The use of personal protective equipment prevented spread of infection in patients and co-workers. With the increase of people being fully vaccinated, it is still necessary to follow infection preventive protocols by correctly applying personal protective equipment. Although high efficacy has been proved, some individuals may still be vulnerable to symptomatic infection and new guidelines and markers should be adopted and investigated to find out patients for whom vaccination may not determine full immunization.

Suggested Citation

  • Vito Carlo Alberto Caponio & Maria Rosaria Lipsi & Francesca Fortunato & Fabio Arena & Lorenzo Lo Muzio, 2022. "Symptomatic SARS-CoV-2 Infection with Ageusia after Two mRNA Vaccine Doses," IJERPH, MDPI, vol. 19(2), pages 1-5, January.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:2:p:886-:d:724240
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/2/886/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/2/886/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:2:p:886-:d:724240. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.